Trial Profile
Comparison of safety and efficacy results between etanercept, adalimumab and tocilizumab in patients with polyarticular juvenile idiopathic arthritis: A German BIKER registry study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jan 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Tocilizumab (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 30 Jan 2017 New trial record